Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer

C C Cook1, A Kim, S Terao

  • 1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Cell Death & Disease
|January 20, 2012
PubMed

Insights

Loss of mitochondrial genome in cancer cells triggers Ras activation, promoting aggressive tumor growth. This occurs via a pathway involving HMGR overexpression and altered oxygen levels, linking mitochondrial health to cancer progression.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Mitochondrial genome alterations are common in cancer, but mechanisms driving advanced phenotypes remain unclear.
  • Proto-oncogenic Ras proteins play a critical role in cancer cell signaling and proliferation.
  • The mevalonate pathway, regulated by HMGR, is crucial for cellular biosynthesis and signaling.

Purpose of the Study:

  • To elucidate the mechanism linking mitochondrial genome loss to cancer progression.
  • To investigate the role of Ras activation in mitochondrial genome-associated cancer phenotypes.
  • To explore the involvement of the mevalonate pathway and hypoxia in this process.

Main Methods:

  • Investigated changes in mitochondrial genome content in cancer cells.
  • Assessed the expression and activation of Ras, AKT, and ERK signaling pathways.
  • Measured oxygen consumption and cellular oxygen concentration.
  • Analyzed the expression of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGR) under varying oxygen conditions.
  • Utilized in vitro cell line models and in vivo tissue specimens of prostate and breast cancer.

Main Results:

  • Loss of mitochondrial genome led to reversible overexpression and activation of Ras, particularly K-Ras 4A.
  • Ras activation was mediated by HMGR overexpression, induced by a hypoxic-to-normoxic shift.
  • Reduced mitochondrial genome content decreased oxygen consumption, creating a normoxic environment that upregulated HMGR.
  • This pathway was linked to advanced phenotypes in prostate and breast cancer cells and tissues.

Conclusions:

  • Mitochondrial genome reduction promotes cancer progression by inducing HMGR overexpression and Ras activation via oxygen level changes.
  • This study reveals a novel mechanism connecting mitochondrial integrity to aggressive cancer phenotypes.
  • Targeting this pathway could offer new therapeutic strategies for advanced prostate and breast cancers.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...